YLT-11
Product Specifications
Target
Apoptosis, PLK, Others
Related Pathways
Apoptosis, Others, Cell Cycle/Checkpoint
Bioactivity
YLT-11 is a potent, selective, and orally active inhibitor of polo-like kinase 4 (PLK4), with dissociation constant (Kd) values of >10000 nM for PLK1, 653 nM for PLK2, >10000 nM for PLK3, and 5.2 nM for PLK4. It demonstrates antiproliferative effects, induces apoptosis, and causes cell cycle arrest at the G2/M phase, highlighting its anticancer activity.
Smiles
CC(=O)NC1=NC=CC(=N1)C2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=C(C=C4)CN(C)C
Molecular Formula
C24H24N6O
Molecular Weight
412.49
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-63012R-PE-Cy5.5 100 µL
USP22 Recombinant Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details MBS6311000-01 0.1 mL
IRX5, CT (IRX5, IRX2A, IRXB2, Iroquois-class homeodomain protein IRX-5, Homeodomain protein IRX-2A, Homeodomain protein IRXB2, Iroquois homeobox protein 5) (MaxLight 550)
Sign In for Pricing
View Details MBS6311000-02 5x 0.1 mL
IRX5, CT (IRX5, IRX2A, IRXB2, Iroquois-class homeodomain protein IRX-5, Homeodomain protein IRX-2A, Homeodomain protein IRXB2, Iroquois homeobox protein 5) (MaxLight 550)
Sign In for Pricing
View Details